AlphAIAlphAI — Financial news for AI agents
SEC EDGARSEP 181 min read$BLBD

Sanfrey Jeffrey Scott sold $250K of BLBD

Sanfrey Jeffrey Scott (Chief Operating Officer) sold 4,000 shares of Blue Bird Corp (BLBD) at $62.40 ($0.25M total) on 2026-09-16.

Original reporting
SEC EDGAR · Sanfrey Jeffrey Scott
Published Sep 18, 2026, 2:25 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Sep 18, 2026, 2:30 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
About AlphAI AI DeskScoring methodologyReport an issue
AlphAI market briefInsider activity
Primary signal
$BLBD
Neutral
high confidence
Mentioned
$BLBD
Relevance
4/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$BLBDNeutralLow
01

Why it matters

The sale is routine and unlikely to affect BLBD's stock price.

02

Market read

Minor insider sale with limited market impact.

03

What to watch

Potential upcoming corporate actions not disclosed.

Relevance 4/10Novelty 4/10Timing: filed today

Background

Form 4 filings disclose insider transactions; traders monitor for signals of confidence.

Company-level read

Ticker impact

$BLBDNeutralHigh confidence
Context

COO Sanfrey Jeffrey Scott sold 4,000 shares for $249,600 on 2026-09-16, reducing his stake to 35,011 shares.

Expected impact

no significant impact

Evidence & confidence

Sale size is modest relative to float and disclosed as a routine Form 4.

Market effects

Sector

none

Regional

none

Global

none

Counterpoint

What could challenge this read

Insider sale could signal concerns, but size is too small to infer.

Key entities

  • company
    Blue Bird Corp

    US‑listed manufacturer of school buses.

  • person
    Sanfrey Jeffrey Scott

    Chief Operating Officer of Blue Bird Corp.

Read at source← All news

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

BLBD insider trading history →

Related articles

OCT 6
$BLBDMedAI 8/10

Blue Bird Secures $600 Million Credit Facility Led By BMO And Bank Of America

Blue Bird completed a $600 million credit facility refinancing, doubling its borrowing capacity and extending maturity to 2031. The new facility includes a $300 million revolving credit line and a $300 million term loan. The company had $86 million in carry-over debt and $670 million in available liquidity at closing. The refinancing reduced borrowing costs and increased the maximum leverage ratio. BMO and Bank of America led the facility.

pulse2.com2 min
OCT 6
$BLBDMedAI 8/10

Blue Bird closes $600 million credit facility refinancing

Blue Bird Corporation (BLBD) closed a $600M senior secured credit facility, replacing its $250M facilities. The new agreement includes a $300M revolving credit facility and a $300M delayed draw term loan, extending maturity to 2031. The funds will refinance debt and support projects. At closing, BLBD had $86M debt drawn and $670M in available liquidity. The interest rate margin decreased, and the maximum net leverage ratio increased to 3.25x.

investing.com2 min
OCT 6
$BLBDHighAI 8/10

Blue Bird Secures $600 Million Facilities to 2031; Micro Bird Gets C$35 Million Line

Blue Bird Corp. amended its credit facilities, increasing total capacity to $600 million and extending maturities to 2031. The revised terms include a $300 million revolving credit facility and a $300 million delayed draw term loan, with reduced pricing and enhanced covenant flexibility. Additionally, its Micro Bird subsidiaries secured a C$35 million line of credit with TD Bank, backed by a $30 million letter of credit from Bank of Montreal.

tradingview.com1 min
AUG 10
$BLBDMed

Why Blue Bird (BLBD) Shares Are Plunging Today

Blue Bird (NASDAQ: BLBD) shares fell 6.4% after Q3 results. The company reported revenue of $517.2M, above analysts’ $498.1M, with 29.9% YoY growth and 42.9% higher sales volume. Adjusted EPS was $1.28 vs $1.30 consensus, and free cash flow margin fell to 4.2% from 13.1%. Guidance was reaffirmed, not raised.

financialcontent.com6 min